第一单位：
Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.;Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
作者：
Pilar,Mur [1]
;
Nuria,Bonifaci [2]
;
Anna,Díez-Villanueva [3]
;
Elisabet,Munté [2]
;
Maria Henar,Alonso [3]
;
Mireia,Obón-Santacana [3]
;
Gemma,Aiza [2]
;
Matilde,Navarro [1]
;
Virginia,Piñol [4]
;
Joan,Brunet [5]
;
Ian,Tomlinson [6]
;
Gabriel,Capellá [1]
;
Victor,Moreno [7]
;
Laura,Valle [1]
作者单位：
Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.;Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
[1]
Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.;Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.
[2]
Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.;Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.;Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.
[3]
Gastroenterology Unit, Hospital Universitario de Girona Dr Josep Trueta, 17007 Girona, Spain.;School of Medicine, University of Girona, 17071 Girona, Spain.
[4]
Hereditary Cancer Program, Catalan Institute of Oncology, 08908 Barcelona, Spain.;Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.;School of Medicine, University of Girona, 17071 Girona, Spain.;Catalan Institute of Oncology, IDIBGi, 17007 Girona, Spain.
[5]
Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh EH4 2XR, UK.
[6]
Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain.;Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, IDIBELL, 08908 Barcelona, Spain.;Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.;Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, 08907 Barcelona, Spain.
[7]
DOI
10.3390/cancers13153857
PMID
34359758
发布时间
2025-05-30
换一批
